Andres Obregon-Henao, Ph.D. - Publications

Affiliations: 
2013 Microbiology, Immunology, & Pathology Colorado State University, Fort Collins, CO 
Area:
Microbiology Biology

22 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2023 Palčeková Z, Obregón-Henao A, De K, Walz A, Lam H, Philp J, Angala SK, Patterson J, Pearce C, Zuberogoitia S, Avanzi C, Nigou J, McNeil M, Muñoz Gutiérrez JF, Gilleron M, et al. Role of succinyl substituents in the mannose-capping of lipoarabinomannan and control of inflammation in Mycobacterium tuberculosis infection. Plos Pathogens. 19: e1011636. PMID 37669276 DOI: 10.1371/journal.ppat.1011636  0.362
2022 Dutt TS, Karger BR, Fox A, Youssef N, Dadhwal R, Ali MZ, Patterson J, Creissen E, Rampacci E, Cooper SK, Podell BK, Gonzalez-Juarrero M, Obregon-Henao A, Henao-Tamayo M. Mucosal exposure to non-tuberculous mycobacteria elicits B cell-mediated immunity against pulmonary tuberculosis. Cell Reports. 41: 111783. PMID 36516760 DOI: 10.1016/j.celrep.2022.111783  0.409
2020 Frenkel JDH, Ackart DF, Todd AK, DiLisio JE, Hoffman S, Tanner S, Kiran D, Murray M, Chicco A, Obregón-Henao A, Podell BK, Basaraba RJ. Metformin enhances protection in guinea pigs chronically infected with Mycobacterium tuberculosis. Scientific Reports. 10: 16257. PMID 33004826 DOI: 10.1038/s41598-020-73212-y  0.355
2020 Tiwari S, Dutt TS, Chen B, Chen M, Kim J, Dai AZ, Lukose R, Shanley C, Fox A, Karger BR, Porcelli SA, Chan J, Podell BK, Obregon-Henao A, Orme IM, et al. BCG-Prime and boost with Esx-5 secretion system deletion mutant leads to better protection against clinical strains of Mycobacterium tuberculosis. Vaccine. PMID 32978002 DOI: 10.1016/j.vaccine.2020.08.004  0.437
2019 Ramos L, Obregon-Henao A, Henao-Tamayo M, Bowen R, Izzo A, Lunney JK, Gonzalez-Juarrero M. Minipigs as a neonatal animal model for tuberculosis vaccine efficacy testing. Veterinary Immunology and Immunopathology. 215: 109884. PMID 31420066 DOI: 10.1016/J.Vetimm.2019.109884  0.415
2019 Jeon AB, Ackart DF, Li W, Jackson M, Melander RJ, Melander C, Abramovitch RB, Chicco AJ, Basaraba RJ, Obregón-Henao A. 2-aminoimidazoles collapse mycobacterial proton motive force and block the electron transport chain. Scientific Reports. 9: 1513. PMID 30728417 DOI: 10.1038/S41598-018-38064-7  0.426
2017 Ramos L, Obregon-Henao A, Henao-Tamayo M, Bowen R, Lunney JK, Gonzalez-Juarrero M. The minipig as an animal model to study Mycobacterium tuberculosis infection and natural transmission. Tuberculosis (Edinburgh, Scotland). 106: 91-98. PMID 28802411 DOI: 10.1016/J.Tube.2017.07.003  0.443
2017 Jeon AB, Obregón-Henao A, Ackart DF, Podell BK, Belardinelli JM, Jackson M, Nguyen TV, Blackledge MS, Melander RJ, Melander C, Johnson BK, Abramovitch RB, Basaraba RJ. 2-aminoimidazoles potentiate ß-lactam antimicrobial activity against Mycobacterium tuberculosis by reducing ß-lactamase secretion and increasing cell envelope permeability. Plos One. 12: e0180925. PMID 28749949 DOI: 10.1371/Journal.Pone.0180925  0.459
2017 Sanchez-Hidalgo A, Obregón-Henao A, Wheat WH, Jackson M, Gonzalez-Juarrero M. Mycobacterium bovis hosted by free-living-amoebae permits their long-term persistence survival outside of host mammalian cells and remain capable of transmitting disease to mice. Environmental Microbiology. PMID 28585299 DOI: 10.1111/1462-2920.13810  0.375
2016 Li W, Obregón-Henao A, Wallach JB, North EJ, Lee RE, Gonzalez-Juarrero M, Schnappinger D, Jackson M. Therapeutic potential of the Mycobacterium tuberculosis mycolic acid transporter, MmpL3. Antimicrobial Agents and Chemotherapy. PMID 27297488 DOI: 10.1128/Aac.00826-16  0.468
2015 Henao-Tamayo MI, Obregón-Henao A, Arnett K, Shanley CA, Podell B, Orme IM, Ordway DJ. Effect of bacillus Calmette-Guérin vaccination on CD4+Foxp3+ T cells during acquired immune response to Mycobacterium tuberculosis infection. Journal of Leukocyte Biology. PMID 26590147 DOI: 10.1189/Jlb.4A0614-308Rr  0.44
2015 Obregón-Henao A, Arnett KA, Henao-Tamayo M, Massoudi L, Creissen E, Andries K, Lenaerts AJ, Ordway DJ. Susceptibility of Mycobacterium abscessus to Antimycobacterial Drugs in Preclinical Models. Antimicrobial Agents and Chemotherapy. 59: 6904-12. PMID 26303795 DOI: 10.1128/Aac.00459-15  0.426
2015 Schiebler M, Brown K, Hegyi K, Newton SM, Renna M, Hepburn L, Klapholz C, Coulter S, Obregón-Henao A, Henao Tamayo M, Basaraba R, Kampmann B, Henry KM, Burgon J, Renshaw SA, et al. Functional drug screening reveals anticonvulsants as enhancers of mTOR-independent autophagic killing of Mycobacterium tuberculosis through inositol depletion. Embo Molecular Medicine. 7: 127-39. PMID 25535254 DOI: 10.15252/Emmm.201404137  0.405
2015 Henao-Tamayo M, Obregón-Henao A, Creissen E, Shanley C, Orme I, Ordway DJ. Differential Mycobacterium bovis BCG vaccine-derived efficacy in C3Heb/FeJ and C3H/HeOuJ mice exposed to a clinical strain of Mycobacterium tuberculosis. Clinical and Vaccine Immunology : Cvi. 22: 91-8. PMID 25392011 DOI: 10.1128/Cvi.00466-14  0.43
2014 Podell BK, Ackart DF, Obregon-Henao A, Eck SP, Henao-Tamayo M, Richardson M, Orme IM, Ordway DJ, Basaraba RJ. Increased severity of tuberculosis in Guinea pigs with type 2 diabetes: a model of diabetes-tuberculosis comorbidity. The American Journal of Pathology. 184: 1104-18. PMID 24492198 DOI: 10.1016/J.Ajpath.2013.12.015  0.372
2013 Obregón-Henao A, Henao-Tamayo M, Orme IM, Ordway DJ. Gr1(int)CD11b+ myeloid-derived suppressor cells in Mycobacterium tuberculosis infection. Plos One. 8: e80669. PMID 24224058 DOI: 10.1371/Journal.Pone.0080669  0.52
2013 Sun J, Singh V, Lau A, Stokes RW, Obregón-Henao A, Orme IM, Wong D, Av-Gay Y, Hmama Z. Mycobacterium tuberculosis nucleoside diphosphate kinase inactivates small GTPases leading to evasion of innate immunity. Plos Pathogens. 9: e1003499. PMID 23874203 DOI: 10.1371/Journal.Ppat.1003499  0.443
2012 Kato-Maeda M, Shanley CA, Ackart D, Jarlsberg LG, Shang S, Obregon-Henao A, Harton M, Basaraba RJ, Henao-Tamayo M, Barrozo JC, Rose J, Kawamura LM, Coscolla M, Fofanov VY, Koshinsky H, et al. Beijing sublineages of Mycobacterium tuberculosis differ in pathogenicity in the guinea pig. Clinical and Vaccine Immunology : Cvi. 19: 1227-37. PMID 22718126 DOI: 10.1128/Cvi.00250-12  0.411
2012 Palanisamy GS, Kirk NM, Ackart DF, Obregón-Henao A, Shanley CA, Orme IM, Basaraba RJ. Uptake and accumulation of oxidized low-density lipoprotein during mycobacterium tuberculosis infection in guinea pigs Plos One. 7. PMID 22493658 DOI: 10.1371/Journal.Pone.0034148  0.446
2011 Ordway DJ, Shang S, Henao-Tamayo M, Obregon-Henao A, Nold L, Caraway M, Shanley CA, Basaraba RJ, Duncan CG, Orme IM. Mycobacterium bovis BCG-mediated protection against W-Beijing strains of Mycobacterium tuberculosis is diminished concomitant with the emergence of regulatory T cells. Clinical and Vaccine Immunology : Cvi. 18: 1527-35. PMID 21795460 DOI: 10.1128/Cvi.05127-11  0.433
2011 Obregón-Henao A, Shanley C, Bianco MV, Cataldi AA, Basaraba RJ, Orme IM, Bigi F. Vaccination of guinea pigs using mce operon mutants of Mycobacterium tuberculosis. Vaccine. 29: 4302-7. PMID 21515327 DOI: 10.1016/J.Vaccine.2011.04.027  0.503
2008 Kaur D, Obregón-Henao A, Pham H, Chatterjee D, Brennan PJ, Jackson M. Lipoarabinomannan of Mycobacterium: mannose capping by a multifunctional terminal mannosyltransferase. Proceedings of the National Academy of Sciences of the United States of America. 105: 17973-7. PMID 19004785 DOI: 10.1073/Pnas.0807761105  0.388
Show low-probability matches.